Pharmaceuticals, Biotechnology & Life Sciences

Amgen Set to Release Q2 Financials Amid Market Challenges and Growth Opportunities in Biotech

Amgen is set to release its second quarter financial results on August 5, 2025, amidst market leading artists, and the theme parkour Street characters. 2 Date: 2025/07-07T00:55:00.000Z Source: www.finanews.com

Sands China’s shares price-Part of Ex…

2025-08-01

2 minutes to read

Takeda Reports 8.39% Sales Decline Amid Strong R&D Focus

Takeda Pharmaceutical Co Ltd reported an 8.39% decline in sales and a decrease in earnings per share, but maintains strong long-term prospects driven by research and development in key areas.

2025-08-01

One minute to read

Novartis Celebrates FDA Approval for Leqvio Amid Trump’s Price Pressure Concerns

Novartis receives FDA approval for its medication Leqvio, but its stock price is impacted by US President Trump’s demands for lower medication prices.

2025-08-01

2 minutes to read

Eisai’s LEQEMBI(R) Revolutionizes Alzheimer’s Treatment with Promising Clinical Results and Revenue Growth

Eisai’s LEQEMBI(R) treatment for Alzheimer’s disease has shown significant progress, with strong sales and new clinical data highlighting its effectiveness in slowing disease progression.

2025-08-01

2 minutes to read

Otsuka Holdings Soars in Earnings, But Can It Maintain Its Flight?

Otsuka Holdings Co., Ltd. reports strong first half earnings, but investors should exercise caution and carefully evaluate the company’s financials to determine if the momentum can be sustained.

2025-08-01

2 minutes to read

QIAGEN NV Stock Rises on Positive Analyst Outlook and Molecular Diagnostics Growth

QIAGEN NV’s stock price has seen a moderate increase due to analysts’ optimistic views on the company’s prospects in the growing molecular diagnostics market.

2025-08-01

One minute to read

Galderma Group AG Faces Market Shift After Major Share Sale by EQT

Galderma Group AG’s stock price plummeted 8% after EQT sold 17 million shares, resulting in a significant impact on the company’s market capitalization.

2025-08-01

One minute to read

Pfizer Inc: Riding High on Growth Prospects and Innovation in Pharmaceuticals

Pfizer Inc’s stock price has reached a 52-week high, driven by its focus on oncology and other therapeutic areas, with analysts predicting significant growth over the next five years.

2025-08-01

2 minutes to read

Haleon PLC Sees Profit Rise Amid Revenue Forecast Cut and Share Buyback Expansion

Haleon PLC reports mixed financial results for the first half of the year, with pre-tax profit up but revenue growth forecast reduced due to weak demand in North America.

2025-07-31

One minute to read

Ono Pharmaceutical to Report Quarterly Earnings with Expected EPS Growth Amid Industry Advances

Ono Pharmaceutical Co Ltd is set to announce its quarterly earnings on August 1st, with analysts predicting an 8.82% rise in sales.

2025-07-31

One minute to read